Articles by Esther Baranov
Comparison of intestinal histopathological changes following teclistamab, BCMA-directed CAR T, CD19-directed CAR T and rituximab therapies
axi-cel axicabtagene ciloleucel BCMA B-cell maturation antigen BiTE bispecific T-cell engager brexu-cel brexucabtagene autoleucel CAR T Chimeric antigen receptor T cells cilta-cel ciltacabtagene autoleucel CVID common variable immunodeficiency H&E haematoxylin and eosin ide-cel idecabtagene vicleucel IEL intraepithelial lymphocytosis IHC immunohistochemistry liso-cel lisocabtagene maraleucel obe-cel obecabtagene autoleucel tisa-cel tisagenlecleucel Introduction As the use of immunotherapies...
Show More
loading
Actions
Is this you?
As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.Get in touch with Esther
Contact Esther, search articles and posts on X, monitor coverage, and track replies from one place.
Learn more about Muck Rack